|
Market Closed -
Borsa Italiana
09:15:00 23/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.085 EUR | -0.46% |
|
-1.81% | -26.19% |
| 31/08 | Milan in the pink at the open, oil stocks lead the MIB | AN |
| 31/08 | Futures weak; Brent higher after US-Iran attacks | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.46% | -1.81% | -26.19% | -8.82% | 1.06Cr | ||
| -1.85% | +1.05% | +53.92% | +108.18% | 1,04300Cr | ||
| -0.49% | +0.30% | +51.82% | +67.28% | 65TCr | ||
| -0.14% | +0.98% | +19.08% | +71.41% | 47TCr | ||
| -0.25% | +0.19% | +36.95% | +45.54% | 35TCr | ||
| +0.98% | +2.91% | +20.59% | +27.14% | 27TCr | ||
| -1.91% | +2.42% | +10.41% | +11.04% | 26TCr | ||
| -0.92% | +8.00% | +41.71% | +52.30% | 22TCr | ||
| -1.42% | +2.03% | +31.71% | +101.36% | 19TCr | ||
| -2.53% | -7.47% | -32.63% | -60.41% | 18TCr | ||
| Average | -0.84% | +1.84% | +20.74% | +41.50% | 36.33TCr | |
| Weighted average by Cap. | -0.93% | +2.19% | +35.71% | +65.10% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















